Literature DB >> 26892652

Familial skin cancer syndromes: Increased melanoma risk.

Katherine J Ransohoff1, Prajakta D Jaju, Prajaka D Jaju1, Jean Y Tang1, Michele Carbone2, Sancy Leachman3, Kavita Y Sarin4.   

Abstract

Phenotypic traits, such as red hair and freckling, increase melanoma risk by 2- to 3-fold. In addition, approximately 10% of melanomas are caused by inherited germline mutations that increase melanoma risk from 4- to >1000-fold. This review highlights the key genes responsible for inherited melanoma, with an emphasis on when a patient should undergo genetic testing. Many genetic syndromes associated with increased melanoma risk are also associated with an increased risk of other cancers. Identification of these high-risk patients is essential for preventive behavior reinforcement, genetic counseling, and ensuring other required cancer screenings.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  genetic syndromes; genetics; inherited cancer risk; melanoma; oncogenes; skin cancer; tumor suppressor

Mesh:

Year:  2016        PMID: 26892652     DOI: 10.1016/j.jaad.2015.09.070

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

Review 1.  Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.

Authors:  Michele Carbone; Harvey I Pass; Guntulu Ak; H Richard Alexander; Paul Baas; Francine Baumann; Andrew M Blakely; Raphael Bueno; Aleksandra Bzura; Giuseppe Cardillo; Jane E Churpek; Irma Dianzani; Assunta De Rienzo; Mitsuru Emi; Salih Emri; Emanuela Felley-Bosco; Dean A Fennell; Raja M Flores; Federica Grosso; Nicholas K Hayward; Mary Hesdorffer; Chuong D Hoang; Peter A Johansson; Hedy L Kindler; Muaiad Kittaneh; Thomas Krausz; Aaron Mansfield; Muzaffer Metintas; Michael Minaai; Luciano Mutti; Maartje Nielsen; Kenneth O'Byrne; Isabelle Opitz; Sandra Pastorino; Francesca Pentimalli; Marc de Perrot; Antonia Pritchard; Robert Taylor Ripley; Bruce Robinson; Valerie Rusch; Emanuela Taioli; Yasutaka Takinishi; Mika Tanji; Anne S Tsao; A Murat Tuncer; Sebastian Walpole; Andrea Wolf; Haining Yang; Yoshie Yoshikawa; Alicia Zolondick; David S Schrump; Raffit Hassan
Journal:  J Thorac Oncol       Date:  2022-04-21       Impact factor: 20.121

2.  Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis.

Authors:  Kelly M Bailey; Alison B Durham; Lili Zhao; Doug Fullen; James Geiger; Carol Bradford; Valerie Opipari; Timothy Johnson; Rajen Mody
Journal:  Transl Pediatr       Date:  2018-07

Review 3.  Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Authors:  Mariah M Johnson; Sancy A Leachman; Lisa G Aspinwall; Lee D Cranmer; Clara Curiel-Lewandrowski; Vernon K Sondak; Clara E Stemwedel; Susan M Swetter; John Vetto; Tawnya Bowles; Robert P Dellavalle; Larisa J Geskin; Douglas Grossman; Kenneth F Grossmann; Jason E Hawkes; Joanne M Jeter; Caroline C Kim; John M Kirkwood; Aaron R Mangold; Frank Meyskens; Michael E Ming; Kelly C Nelson; Michael Piepkorn; Brian P Pollack; June K Robinson; Arthur J Sober; Shannon Trotter; Suraj S Venna; Sanjiv Agarwala; Rhoda Alani; Bruce Averbook; Anna Bar; Mirna Becevic; Neil Box; William E Carson; Pamela B Cassidy; Suephy C Chen; Emily Y Chu; Darrel L Ellis; Laura K Ferris; David E Fisher; Kari Kendra; David H Lawson; Philip D Leming; Kim A Margolin; Svetomir Markovic; Mary C Martini; Debbie Miller; Debjani Sahni; William H Sharfman; Jennifer Stein; Alexander J Stratigos; Ahmad Tarhini; Matthew H Taylor; Oliver J Wisco; Michael K Wong
Journal:  Melanoma Manag       Date:  2017-03-01

4.  Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.

Authors:  Katherine J Ransohoff; Wenting Wu; Hyunje G Cho; Harvind C Chahal; Yuan Lin; Hong-Ji Dai; Christopher I Amos; Jeffrey E Lee; Jean Y Tang; David A Hinds; Jiali Han; Qingyi Wei; Kavita Y Sarin
Journal:  Oncotarget       Date:  2017-03-14

5.  Identification, genetic testing, and management of hereditary melanoma.

Authors:  Sancy A Leachman; Olivia M Lucero; Jone E Sampson; Pamela Cassidy; William Bruno; Paola Queirolo; Paola Ghiorzo
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

6.  Inhibition of Axl Promotes the Therapeutic Effect of Targeted Inhibition of the PI3K/Akt Pathway in NRAS Mutant Melanoma Cells.

Authors:  Xuejun Gao; Dandan Xue; Jingjing Cheng; Xin Zhang; Xia Cai
Journal:  J Oncol       Date:  2022-03-11       Impact factor: 4.375

Review 7.  Epigenetics of Cutaneous T-Cell Lymphomas.

Authors:  Natsumi Hara; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

8.  Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature.

Authors:  Leandro Jonata Carvalho Oliveira; Aline Bobato Lara Gongora; Fabiola Ambrosio Silveira Lima; Felipe Sales Nogueira Amorim Canedo; Carla Vanessa Quirino; Janina Pontes Pisani; Maria Isabel Achatz; Benedito Mauro Rossi
Journal:  Hered Cancer Clin Pract       Date:  2021-07-21       Impact factor: 2.857

9.  Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from 1973-2014.

Authors:  Emily D Cai; Susan M Swetter; Kavita Y Sarin
Journal:  J Am Acad Dermatol       Date:  2018-10-01       Impact factor: 15.487

10.  Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development.

Authors:  William Bruno; Virginia Andreotti; Alessandra Bisio; Lorenza Pastorino; Giuseppe Fornarini; Stefania Sciallero; Giovanna Bianchi-Scarrà; Alberto Inga; Paola Ghiorzo
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.